These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20932966)

  • 1. HDL-C concentration is related to markers of absorption and of cholesterol synthesis: Study in subjects with low vs. high HDL-C.
    Nunes VS; Leança CC; Panzoldo NB; Parra E; Cazita PM; Nakandakare ER; de Faria EC; Quintão EC
    Clin Chim Acta; 2011 Jan; 412(1-2):176-80. PubMed ID: 20932966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dalcetrapib, a CETP modulator, on non-cholesterol sterol markers of cholesterol homeostasis in healthy subjects.
    Niesor EJ; Chaput E; Staempfli A; Blum D; Derks M; Kallend D
    Atherosclerosis; 2011 Dec; 219(2):761-7. PubMed ID: 21982411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase.
    Nakamura Y; Kotite L; Gan Y; Spencer TA; Fielding CJ; Fielding PE
    Biochemistry; 2004 Nov; 43(46):14811-20. PubMed ID: 15544352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased apolipoprotein E level and reduced high-density lipoprotein mean particle size associate with low high-density lipoprotein cholesterol and features of metabolic syndrome.
    Söderlund S; Watanabe H; Ehnholm C; Jauhiainen M; Taskinen MR
    Metabolism; 2010 Oct; 59(10):1502-9. PubMed ID: 20206948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesteryl ester transfer protein in metabolic syndrome.
    Sandhofer A; Kaser S; Ritsch A; Laimer M; Engl J; Paulweber B; Patsch JR; Ebenbichler CF
    Obesity (Silver Spring); 2006 May; 14(5):812-8. PubMed ID: 16855190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between phytosterol levels and components of the metabolic syndrome in the PROCAM study.
    Assmann G; Cullen P; Kannenberg F; Schulte H
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):208-14. PubMed ID: 17446798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOMA-IR and non-HDL-C as predictors of high cholesteryl ester transfer protein activity in patients at risk for type 2 diabetes.
    Coniglio RI; Meroño T; Montiel H; Malaspina MM; Salgueiro AM; Otero JC; Ferraris R; Schreier L; Brites F; Gómez Rosso L
    Clin Biochem; 2012 May; 45(7-8):566-70. PubMed ID: 22366373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial.
    Hajer GR; Dallinga-Thie GM; van Vark-van der Zee LC; Olijhoek JK; Visseren FL
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):870-7. PubMed ID: 18394022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The possible role of genetic factors in the cholesterol high density lipoprotein level in the Moscow population].
    Slominskiĭ PA; Metel'skaia VA; Miloserdova OV; Perova NV; Limborskaia SA
    Genetika; 2000 Oct; 36(10):1401-5. PubMed ID: 11094754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase activities in hispanic and anglo postmenopausal women: associations with total and regional body fat.
    Greaves KA; Going SB; Fernandez ML; Milliken LA; Lohman TG; Bassford T; McNamara DJ
    Metabolism; 2003 Mar; 52(3):282-9. PubMed ID: 12647264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R; Borggreve SE; Dullaart RP
    Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
    Chan DC; Watts GF; Barrett PH; O'Neill FH; Thompson GR
    Obes Res; 2003 Apr; 11(4):591-6. PubMed ID: 12690090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of plasma cholesterol and lipoprotein parameters are related to a higher degree of insulin sensitivity in high HDL-C healthy normal weight subjects.
    Leança CC; Nunes VS; Panzoldo NB; Zago VS; Parra ES; Cazita PM; Jauhiainen M; Passarelli M; Nakandakare ER; de Faria EC; Quintão EC
    Cardiovasc Diabetol; 2013 Nov; 12():173. PubMed ID: 24267726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects.
    Plomgaard P; Dullaart RP; de Vries R; Groen AK; Dahlbäck B; Nielsen LB
    J Intern Med; 2009 Sep; 266(3):258-67. PubMed ID: 19457058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome.
    Ooi EM; Watts GF; Barrett PH; Chan DC; Clifton PM; Ji J; Nestel PJ
    Asia Pac J Clin Nutr; 2007; 16(4):624-31. PubMed ID: 18042521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum adipokines are associated with cholesterol metabolism in the metabolic syndrome.
    Hallikainen M; Kolehmainen M; Schwab U; Laaksonen DE; Niskanen L; Rauramaa R; Pihlajamäki J; Uusitupa M; Miettinen TA; Gylling H
    Clin Chim Acta; 2007 Aug; 383(1-2):126-32. PubMed ID: 17573060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDL2 of heavy alcohol drinkers enhances cholesterol efflux from raw macrophages via phospholipid-rich HDL 2b particles.
    Mäkelä SM; Jauhiainen M; Ala-Korpela M; Metso J; Lehto TM; Savolainen MJ; Hannuksela ML
    Alcohol Clin Exp Res; 2008 Jun; 32(6):991-1000. PubMed ID: 18498551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsomal enzyme inducers raise plasma high-density lipoprotein cholesterol levels in healthy control subjects but not in patients with primary hypoalphalipoproteinemia.
    Franceschini G; Werba JP; D'Acquarica AL; Gianfranceschi G; Michelagnoli S; Sirtori CR
    Clin Pharmacol Ther; 1995 Apr; 57(4):434-40. PubMed ID: 7712672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.
    Bajnok L; Seres I; Varga Z; Jeges S; Peti A; Karanyi Z; Juhasz A; Csongradi E; Mezosi E; Nagy EV; Paragh G
    Metabolism; 2007 Nov; 56(11):1542-9. PubMed ID: 17950106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical fitness and reverse cholesterol transport.
    Olchawa B; Kingwell BA; Hoang A; Schneider L; Miyazaki O; Nestel P; Sviridov D
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1087-91. PubMed ID: 15072992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.